Betaxolol improves the survival rate and changes natriuretic peptide expression in rats with heart failure - PubMed (original) (raw)
Comparative Study
. 2003 Jan:41 Suppl 1:S99-103.
Wen Juan, Gurusamy Narasimman, Meilei Ma, Mikio Inoue, Yuki Saito, Mir I I Wahed, Mikio Nakazawa, Go Hasegawa, Makoto Naito, Hitoshi Tachikawa, Naohito Tanabe, Makoto Kodama, Yoshifusa Aizawa, Tadashi Yamamoto, Kenichi Yamaguchi, Toshihiro Takahashi
Affiliations
- PMID: 12693380
Comparative Study
Betaxolol improves the survival rate and changes natriuretic peptide expression in rats with heart failure
Kenichi Watanabe et al. J Cardiovasc Pharmacol. 2003 Jan.
Abstract
The cardioprotective effects of betaxolol were studied in a rat model with heart failure induced by autoimmune myocarditis. Twenty-eight days after immunization, Lewis rats were divided into four groups; 0.1 mg/kg betaxolol per day (group 0.1), 1.0 mg/kg betaxolol per day (group 1), 10 mg/kg betaxolol per day (group 10), and vehicle (0.5% methylcellulose, group V) (all groups, n = 13). After oral administration for 1 month, the heart weight, the mRNA expression of atrial natriuretic peptide and brain natriuretic peptide in the left ventricle, the plasma atrial natriuretic peptide concentration, the mean blood pressure, the heart rate, the central venous pressure, the peak left ventricular pressure, the left ventricular end-diastolic pressure and its first derivative +/-dP/dt, and the area of myocardial fibrosis were measured. Betaxolol reduced the heart rate, the levels of atrial natriuretic peptide and brain natriuretic peptide mRNA expression and the atrial natriuretic peptide concentration [group N (normal rats), 367 +/- 4 beats/min, 100%, 100% and 78 +/- 7 pg/ml, respectively; group V, 391 +/- 9 beats/min, 761 +/- 68% versus group N, 317 +/- 42% versus group N and 4374 +/- 312 pg/ml, respectively; group 0.1, 387 +/- 10 beats/min, 621 +/- 78%, 288 +/- 41% and 2875 +/- 331 pg/ml, respectively; group 1, 323 +/- 9 beats/min, 442 +/- 84%, 148 +/- 12% and 884 +/- 51 pg/ml, respectively; and group 10, 312 +/- 8 beats/min, 97 +/- 18%, 92 + 9% and 453 +/- 53 pg/ml, respectively], and increased survival (group V, 62%; group 0.1, 69%; groups N, 1 and 10, 100%). Betaxolol did not significantly alter the heart weight, the hemodynamic parameters or the area of fibrosis. These observations suggest that betaxolol may improve the survival rate by reducing sudden death and changing the atrial natriuretic peptide and brain natriuretic peptide mRNA expression in patients with heart failure.
Similar articles
- Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy.
Watanabe K, Ohta Y, Nakazawa M, Higuchi H, Hasegawa G, Naito M, Fuse K, Ito M, Hirono S, Tanabe N, Hanawa H, Kato K, Kodama M, Aizawa Y. Watanabe K, et al. Br J Pharmacol. 2000 Aug;130(7):1489-95. doi: 10.1038/sj.bjp.0703450. Br J Pharmacol. 2000. PMID: 10928949 Free PMC article. - Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair.
Tsuneyoshi H, Nishina T, Nomoto T, Kanemitsu H, Kawakami R, Unimonh O, Nishimura K, Komeda M. Tsuneyoshi H, et al. Circulation. 2004 Sep 14;110(11 Suppl 1):II174-9. doi: 10.1161/01.CIR.0000138348.77856.ef. Circulation. 2004. PMID: 15364859 - Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M. Isnard R, et al. Am Heart J. 2003 Oct;146(4):729-35. doi: 10.1016/S0002-8703(03)00365-X. Am Heart J. 2003. PMID: 14564330 - [Natriuretic peptide receptors and heart failure].
Andreassi MG, Del Ry S, Giannessi D. Andreassi MG, et al. Cardiologia. 1999 Mar;44(3):241-8. Cardiologia. 1999. PMID: 10327725 Review. Italian. No abstract available. - Brain natriuretic peptides.
Fachantidou A, Tassoulas E, Biskanaki F, Gill JS. Fachantidou A, et al. Indian Heart J. 1998 Mar-Apr;50(2):155-62. Indian Heart J. 1998. PMID: 9622981 Review. No abstract available.
Cited by
- Diastolic dysfunction: a link between hypertension and heart failure.
Lalande S, Johnson BD. Lalande S, et al. Drugs Today (Barc). 2008 Jul;44(7):503-13. doi: 10.1358/dot.2008.44.7.1221662. Drugs Today (Barc). 2008. PMID: 18806901 Free PMC article. Review. - Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats.
Rudoy CA, Van Bockstaele EJ. Rudoy CA, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1119-29. doi: 10.1016/j.pnpbp.2007.04.005. Epub 2007 Apr 19. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17513029 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical